The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,030.00
Bid: 995.00
Ask: 1,060.00
Change: 0.00 (0.00%)
Spread: 65.00 (6.533%)
Open: 1,030.00
High: 1,030.00
Low: 1,030.00
Prev. Close: 1,027.50
ARBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement and Notice of Meeting

14 May 2020 15:54

RNS Number : 9671M
Arbuthnot Banking Group PLC
14 May 2020
 

14 May 2020

 

ARBUTHNOT BANKING GROUP PLC

 

 

Trading Statement and Notice of Meeting

 

 

Trading Statement

 

As today would normally have been the date of the Company's Annual General Meeting ("AGM") we are, in line with the Company's practice of providing a trading update at the time of its AGM, making the following statement regarding the trading performance of the Group since the start of 2020.

 

The Group had traded well up to the introduction of the Coronavirus lockdown. At the end of March 2020, Customer loan balances were 35% higher than the prior year and had increased by 4% from the level reported at 31 December 2019. New loan origination volumes were 38% greater than the same period in the prior year. Deposit raising activities had also continued with customer deposit balances increasing by 2% from the level at the year-end which itself reflected recent strong underlying growth. Despite the uncertainties in the markets the Investment Management business continued to see net inflows from clients.

 

Following the introduction of the UK Government's public health restrictions, the Group reacted swiftly to protect its staff and clients. All activities have been moved to remote operation with all staff working successfully from home. Client communications with our bankers has been more in-depth and on average longer in duration, which in the long term should prove mutually beneficial, as we continue the progress made in 2019 on developing deeper relationships with clients. At the same time recorded client complaints have fallen in volume.

 

Given the strength of the Group's resources, we have not sought to use any of the emergency support measures that are available from the UK Government; no staff have been placed on furlough or made redundant and we have continued to pay all of our tax liabilities by their original due dates.

 

The Bank has remained open to new introductions and lending opportunities and has funded £26m of new loans during the lockdown. Lending has proved more challenging given the uncertainty that exists in property valuations but other credit mitigants have allowed our bankers to continue to support the clients' needs. The Investment Management business has continued to see net inflows and in line with our cautious private banking approach, ensured that the most popular portfolios saw limited falls in values and as a result, overall in the first four months assets under management fell by 6%.

 

The Group has applied to join the British Business Bank schemes to provide funding to support the SME sector. The Group has also followed the guidance from the Government regarding provision of payment holidays and other forbearance measures. These have been provided where appropriate and without delay.

 

To date the core lending portfolios have seen modest take up of payment holiday requests. The purchased mortgage portfolios have granted payment holidays to 25% of the borrowers and RAF, our asset finance business, has granted payment holidays to 67% of its customers. These appear to be comparable to similar portfolios in the same markets and these loans remain well secured by properties or assets and where appropriate other guarantees.

 

Key metrics such as liquidity and capital have continued to be monitored in the normal fashion and have remained strong.

 

As outlined on 26 March 2020 in our audited 2019 results announcement, the reduction in the base rate to a historically low level, will materially reduce the Group's income and profitability for 2020. However, the Group has taken steps to manage its cost base and, together with the action the Bank of England has taken in reducing capital buffer requirements, anticipates that even after the issues that are likely to arise in the coming months concerning IFRS9 and other credit issues, the Group will have greater surplus capital at the end of 2020 than originally planned. The Board believes that this will provide a robust platform from which the Group should be able to grow strongly, once the economy begins to recover.

 

Notice of Meeting

 

Arbuthnot Banking Group PLC announces that the Company's AGM has now been arranged to be held at Arbuthnot House, 7 Wilson Street, London EC2M 2SN on Tuesday 16 June 2020. At the AGM, Shareholders will be asked to vote on a number of resolutions including the re-appointment of Mazars LLP as the Company's auditor. The resolutions to be put to the Meeting are set out in the Notice of Meeting, available on the Company's website at http://www.arbuthnotgroup.com/results_presentations.html. 

 

The Company is closely monitoring the COVID-19 situation, including UK Government guidance and will continue to do so in the lead up to the AGM. The health of our shareholders, employees and stakeholders remains extremely important to us and accordingly, the Board has taken into consideration the compulsory 'Stay at Home' measures that have been published by the UK Government. These measures provide that public gatherings of more than two people are currently not permitted. Accordingly shareholders, advisers and other guests will not be allowed to attend the AGM in person and anyone seeking to attend the meeting will be refused entry.

 

Shareholders are requested therefore to submit their votes, in respect of the business to be discussed, via proxy as early as possible. Shareholders should appoint the Chairman of the meeting as their proxy. If a shareholder appoints someone else as their proxy, that proxy will not be able to attend the meeting in person or cast the shareholder's vote.

 

The business at the AGM will be curtailed to the formal business section only, with no wider presentations on business performance or Q&A.

 

In the event that further disruption to the 2020 AGM becomes unavoidable, we will announce any changes to the meeting (such as timing or venue) as soon as practicably possible through the Company's website.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

Enquiries:

 

Arbuthnot Banking Group

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

0207 012 2400

 

Grant Thornton UK LLP (Nominated Adviser and

NEX Exchange Corporate Advisor)

Colin Aaronson/Samantha Harrison /Niall McDonald

0207 383 5100

 

Numis Securities Ltd (Joint Broker)

Stephen Westgate

0207 260 1000

 

Shore Capital Ltd (Joint Broker)

Hugh Morgan/Daniel Bush

0207 408 4090

 

Maitland/AMO (Financial PR)

Neil Bennett/Sam Cartwright/Jonathan Cook

0207 379 5151

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBSGDUDUBDGGS
Date   Source Headline
22nd Oct 20084:56 pmRNSTransaction in Own Shares
22nd Oct 20087:00 amRNSTrading Statement
20th Oct 20085:31 pmRNSTransaction in Own Shares
14th Oct 20085:03 pmRNSTransaction in Own Shares
13th Oct 20081:12 pmRNSDirector/PDMR Shareholding
10th Oct 20085:13 pmRNSTransaction in Own Shares
9th Oct 20085:26 pmRNSTransaction in Own Shares
8th Oct 20086:05 pmRNSTransaction in Own Shares
7th Oct 20084:56 pmRNSTransaction in Own Shares
6th Oct 200811:45 amRNSDirectorate Change
16th Sep 20084:58 pmRNSTransaction in Own Shares
15th Sep 20085:37 pmRNSTransaction in Own Shares
30th Jul 20087:00 amRNSInterim Results
1st Jul 20087:00 amRNSDirectorate Change
4th Jun 20083:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20081:10 pmRNSArbuthnot Latham new agreemen
2nd Jun 200812:32 pmRNSDirectorate Change
29th May 20082:50 pmRNSESOP Share Purchase
29th May 20082:30 pmRNSDirector/PDMR Shareholding
27th May 200810:20 amRNSAdditional Listing - Scrip Di
23rd May 200812:58 pmRNSDirector/PDMR Shareholding (R
22nd May 20085:35 pmRNSDirector/PDMR Shareholding
22nd May 20085:23 pmRNSDirector/PDMR Shareholding
15th May 200810:27 amRNSDisposal
14th May 20084:39 pmRNSResult of AGM
14th May 20082:30 pmRNSAGM Statement
24th Apr 200810:42 amRNSPurchase of Share by ESOP
4th Apr 20082:18 pmRNSNotice of AGM
31st Mar 20085:01 pmRNSHolding(s) in Company
13th Mar 20087:01 amRNSFinal Results
15th Jan 20084:07 pmRNSDirectorate Change
11th Jan 20087:00 amRNSTrading Statement
29th Nov 200712:54 pmRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSInterim Results
5th Sep 20079:30 amRNSDirectorate Change
16th Aug 20072:50 pmRNSAIM Rule 26
12th Jul 20071:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20079:33 amRNSPre-Close Trading Update
19th Jun 20077:02 amRNSRandgold - Jt Broker Appt
7th Jun 200711:32 amRNSDirector/PDMR Shareholding
22nd May 20074:57 pmRNSAGM Statement
17th Apr 20071:42 pmRNSDirector/PDMR Shareholding
11th Apr 20074:33 pmRNSAnnual Report & Accounts
22nd Mar 20073:04 pmRNS2005Comparative Supplementary
20th Mar 20077:02 amRNSArbuthnot joins DIFX
20th Mar 20077:02 amRNSFinal Results
13th Mar 20074:45 pmRNSAnalyst Recruitment
22nd Feb 20074:45 pmRNSHolding(s) in Company
12th Feb 20074:00 pmRNSHolding in Company
6th Feb 20073:18 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.